CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 5, 2015--
AVEO Oncology (NASDAQ:AVEO) today announced that management will host a
conference call on Monday, August 10, 2015, at 10:00 a.m. Eastern Time
to provide an update on recent developments and corporate goals, as well
as discuss financial results for the second quarter ended June 30, 2015.
The call can be accessed by dialing 1-866-428-2694 (domestic) or
1-704-908-0403 (international) five minutes prior to the start time and
providing the passcode 98837289. A live webcast of the conference call
can be accessed by visiting the investors section of the AVEO website at www.aveooncology.com.
A replay of the webcast will be archived on the AVEO website for two
weeks following the call.
AVEO Oncology (AVEO) is a biopharmaceutical company committed to
developing targeted therapies through biomarker-driven insights to
provide improvements in patient outcomes where significant unmet medical
needs exist. AVEO’s proprietary Human Response Platform™ has delivered
unique insights into cancer and related disease biology that AVEO is
seeking to leverage in the clinical development strategy of its
therapeutic candidates. For more information, please visit the Company’s
website at www.aveooncology.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150805005705/en/
Source: AVEO Oncology
Company, Media and Investors: